Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 249 entries
View as:

A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03933982 Org: User:
Start: 12/22/18 End: 06/22/22 Due: 06/22/23

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03639467 Org: User:
Start: 09/18/18 End: 08/15/23 Due: 08/15/24

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01494558 Org: User:
Start: 05/31/07 End: 08/31/11 Due: 08/31/12

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04194684 Org: User:
Start: 12/28/19 End: 01/30/23 Due: 01/30/24

Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02209441 Org: User:
Start: - End: - Due: -

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT04491721 Org: User:
Start: 07/31/20 End: 07/31/27 Due: 07/31/28

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03735082 Org: User:
Start: 11/01/18 End: 06/01/20 Due: 06/01/21

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01939054 Org: User:
Start: 09/30/13 End: 09/30/16 Due: 09/30/17

A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04528225 Org: User:
Start: 11/15/17 End: 02/24/20 Due: 02/24/21

FSRT Combined With TMZ for Large BMs: a PSM Study

Phase: N/A Priority: Normal
NCT ID: NCT03338075 Org: User:
Start: 01/01/16 End: 08/01/17 Due: 08/01/18

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03199677 Org: User:
Start: 07/01/17 End: 06/30/18 Due: 06/30/19

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02512380 Org: User:
Start: 07/31/15 End: 07/31/21 Due: 07/31/22

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Phase: N/A Priority: Normal
NCT ID: NCT05216484 Org: User:
Start: 02/18/22 End: 12/30/22 Due: 12/30/23

Everolimus trIal for Advanced prememopausaL Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02313051 Org: User:
Start: 12/31/14 End: 12/31/17 Due: 12/31/18

Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01997372 Org: User:
Start: 12/31/10 End: 11/30/15 Due: 11/30/16

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02688023 Org: User:
Start: 03/31/14 End: 12/31/19 Due: 12/31/20

Purified Inactivated Japanese Encephalitis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04223037 Org: User:
Start: 09/01/15 End: 12/31/22 Due: 12/31/23

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Phase: N/A Priority: Normal
NCT ID: NCT03308552 Org: User:
Start: 12/01/17 End: 08/30/21 Due: 08/30/22

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02429622 Org: User:
Start: 01/31/15 End: 12/31/16 Due: 12/31/17

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04425824 Org: User:
Start: 06/15/20 End: 12/31/22 Due: 12/31/23

Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01679327 Org: User:
Start: 03/31/12 End: 09/30/14 Due: 09/30/15

The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)

Phase: N/A Priority: Normal
NCT ID: NCT03240744 Org: User:
Start: 06/22/17 End: 10/31/20 Due: 10/31/21

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00714077 Org: User:
Start: 04/30/08 End: 06/30/18 Due: 06/30/19

Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02595138 Org: User:
Start: 10/31/15 End: 12/31/23 Due: 12/31/24

Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01674959 Org: User:
Start: 10/31/11 End: 12/31/17 Due: 12/31/18